501 related articles for article (PubMed ID: 12524446)
1. Endogenous RGS protein action modulates mu-opioid signaling through Galphao. Effects on adenylyl cyclase, extracellular signal-regulated kinases, and intracellular calcium pathways.
Clark MJ; Harrison C; Zhong H; Neubig RR; Traynor JR
J Biol Chem; 2003 Mar; 278(11):9418-25. PubMed ID: 12524446
[TBL] [Abstract][Full Text] [Related]
2. Endogenous regulators of G protein signaling differentially modulate full and partial mu-opioid agonists at adenylyl cyclase as predicted by a collision coupling model.
Clark MJ; Linderman JJ; Traynor JR
Mol Pharmacol; 2008 May; 73(5):1538-48. PubMed ID: 18285510
[TBL] [Abstract][Full Text] [Related]
3. Endogenous regulator of g protein signaling proteins reduce {mu}-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells.
Clark MJ; Traynor JR
J Pharmacol Exp Ther; 2005 Feb; 312(2):809-15. PubMed ID: 15383633
[TBL] [Abstract][Full Text] [Related]
4. Assays for G-protein-coupled receptor signaling using RGS-insensitive Galpha subunits.
Clark MJ; Traynor JR
Methods Enzymol; 2004; 389():155-69. PubMed ID: 15313565
[TBL] [Abstract][Full Text] [Related]
5. Differential modulation of mu-opioid receptor signaling to adenylyl cyclase by regulators of G protein signaling proteins 4 or 8 and 7 in permeabilised C6 cells is Galpha subtype dependent.
Talbot JN; Roman DL; Clark MJ; Roof RA; Tesmer JJ; Neubig RR; Traynor JR
J Neurochem; 2010 Feb; 112(4):1026-34. PubMed ID: 20002516
[TBL] [Abstract][Full Text] [Related]
6. Endogenous regulator of G protein signaling proteins suppress Galphao-dependent, mu-opioid agonist-mediated adenylyl cyclase supersensitization.
Clark MJ; Neubig RR; Traynor JR
J Pharmacol Exp Ther; 2004 Jul; 310(1):215-22. PubMed ID: 15014136
[TBL] [Abstract][Full Text] [Related]
7. Mediation of adenylyl cyclase sensitization by PTX-insensitive GalphaoA, Galphai1, Galphai2 or Galphai3.
Clark MJ; Traynor JR
J Neurochem; 2006 Dec; 99(6):1494-504. PubMed ID: 17230639
[TBL] [Abstract][Full Text] [Related]
8. Differential control of opioid antinociception to thermal stimuli in a knock-in mouse expressing regulator of G-protein signaling-insensitive Gαo protein.
Lamberts JT; Smith CE; Li MH; Ingram SL; Neubig RR; Traynor JR
J Neurosci; 2013 Mar; 33(10):4369-77. PubMed ID: 23467353
[TBL] [Abstract][Full Text] [Related]
9. Regulation of adenylyl cyclase, ERK1/2, and CREB by Gz following acute and chronic activation of the delta-opioid receptor.
Tso PH; Yung LY; Wong YH
J Neurochem; 2000 Apr; 74(4):1685-93. PubMed ID: 10737627
[TBL] [Abstract][Full Text] [Related]
10. Modulation of μ-opioid receptor signaling by RGS19 in SH-SY5Y cells.
Wang Q; Traynor JR
Mol Pharmacol; 2013 Feb; 83(2):512-20. PubMed ID: 23197645
[TBL] [Abstract][Full Text] [Related]
11. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
Liu JG; Prather PL
Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
[TBL] [Abstract][Full Text] [Related]
12. Activation of type II adenylyl cyclase by the cloned mu-opioid receptor: coupling to multiple G proteins.
Chan JS; Chiu TT; Wong YH
J Neurochem; 1995 Dec; 65(6):2682-9. PubMed ID: 7595566
[TBL] [Abstract][Full Text] [Related]
13. A role for the distal carboxyl tails in generating the novel pharmacology and G protein activation profile of mu and delta opioid receptor hetero-oligomers.
Fan T; Varghese G; Nguyen T; Tse R; O'Dowd BF; George SR
J Biol Chem; 2005 Nov; 280(46):38478-88. PubMed ID: 16159882
[TBL] [Abstract][Full Text] [Related]
14. Differential modulation of mu- and delta-opioid receptor agonists by endogenous RGS4 protein in SH-SY5Y cells.
Wang Q; Liu-Chen LY; Traynor JR
J Biol Chem; 2009 Jul; 284(27):18357-67. PubMed ID: 19416973
[TBL] [Abstract][Full Text] [Related]
15. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
[TBL] [Abstract][Full Text] [Related]
16. Endogenous RGS proteins attenuate Galpha(i)-mediated lysophosphatidic acid signaling pathways in ovarian cancer cells.
Hurst JH; Henkel PA; Brown AL; Hooks SB
Cell Signal; 2008 Feb; 20(2):381-9. PubMed ID: 18083345
[TBL] [Abstract][Full Text] [Related]
17. Different domains in the third intracellular loop of the GLP-1 receptor are responsible for Galpha(s) and Galpha(i)/Galpha(o) activation.
Hällbrink M; Holmqvist T; Olsson M; Ostenson CG; Efendic S; Langel U
Biochim Biophys Acta; 2001 Mar; 1546(1):79-86. PubMed ID: 11257510
[TBL] [Abstract][Full Text] [Related]
18. Biased μ-opioid receptor agonists diversely regulate lateral mobility and functional coupling of the receptor to its cognate G proteins.
Melkes B; Hejnova L; Novotny J
Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1289-1300. PubMed ID: 27600870
[TBL] [Abstract][Full Text] [Related]
19. Go mediates the coupling of the mu opioid receptor to adenylyl cyclase in cloned neural cells and brain.
Carter BD; Medzihradsky F
Proc Natl Acad Sci U S A; 1993 May; 90(9):4062-6. PubMed ID: 8097884
[TBL] [Abstract][Full Text] [Related]
20. Gi/o-coupled receptors compete for signaling to adenylyl cyclase in SH-SY5Y cells and reduce opioid-mediated cAMP overshoot.
Levitt ES; Purington LC; Traynor JR
Mol Pharmacol; 2011 Mar; 79(3):461-71. PubMed ID: 21098043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
